P4382O2-pulse measure obtained by gas exchange analysis is an accurate esteeme of stroke volume?

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
M Evangelista ◽  
E Alfonzetti ◽  
F Bandera ◽  
M Guazzi

Abstract Background It is axiomatic that exercise performances depends on cardiac output increase. Among several methods for noninvasively estimating stroke volume, O2 pulse (i.e. the ratio of VO2/HR) is generally used during gas exchange analysis, but its accuracy has never been well investigated. Purpose To test the validity and the accuracy of O2 pulse as a measure of stroke volume (SV) in comparison with the echocardiographic methods. Methods From 22nd of August 2016 to 30th of April 2018 our laboratory performed 259 cardiopulmonary exercise tests (CPET) combined with echo. The group of patients was characterized by a heterogeneous spectrum of diseases: 70 coronary artery disease, 10 heart failure with preserved ejection fraction, 13 heart failure with middle ejection fraction, 26 heart failure with reduced ejection fraction, 29 Fabry disease, 7 hypertrophic cardiomyopathy, 10 dilated cardiomyopathy, 30 aortic stenosis, 16 aortic regurgitation, 8 mitral stenosis, 76 mitral regurgitation, 6 tricuspid regurgitation, 7 congenital heart diseases. The median age was 65 yr (52,5; 74,5) and 61,5% of patients was male. In our group are present 20 healthy subjects with normal heart. O2 pulse was measured at rest, at 2 minutes, 4 minutes, 6 minutes and at maximum of stress. In some cases the maximum of stress correspond to 4- or 6-minutes of stress. All the echocardiographic images were taken with Epiq7C, Philips. The left ventricle SV was measured as SV = LVOT area x LVOT VTI, all the measures and the images where acquired by the same operator to reduce at minimum the external error introduce by the operator. Results As first step we analysed the absolute value of O2-pulse and SV at rest and during the different steps of exercise to see if and how they behave. In the figure attached is possible to see that both the values increased during the exercise with a small reduction at the maximum that may be explained by a premature interruption of the exercise. Secondly we analysed the correlation between O2 pulse and LVOT-SV at rest and during 2-, 4-, 6- minutes of exercise and at maximum which was respectively: r=0,23 (p<0,0001), r=0,36 (p<0,0001), r=0,30 (p<0,0001), r=0,25 (p<0,0001) and r=0,51 (p<0,0001) (see figure 2). The analysis has been possible in 259 patients at rest, in 246 at 2-minutes of stress, in 221 at 4-minutes of stress and in 149 patients at 6-minutes of stress. At maximum of exercise, the analysis has been carried out in 229 patients, but we need to keep in mind that maximum of stress includes both 4- and 6-minutes of exercises according to the capability of each patients. Conclusion In our analysis we show an incremental trend during exercise of O2-Pulse value and of LVOT-SV. At rest and during exercise it is present a good correlation between O2-pulse and LVOT-SV. These data reinforce the concept that O2 pulse reflects an estimation of SV and may explain its reported prognostic validity in prospective studies.

2021 ◽  
Vol 8 ◽  
Author(s):  
Qingchun Zeng ◽  
Qing Zhou ◽  
Weitao Liu ◽  
Yutong Wang ◽  
Xingbo Xu ◽  
...  

Heart failure (HF) is a common complication or late-stage manifestation of various heart diseases. Numerous risk factors and underlying causes may contribute to the occurrence and progression of HF. The pathophysiological mechanisms of HF are very complicated. Despite accumulating advances in treatment for HF during recent decades, it remains an intractable clinical syndrome with poor outcomes, significantly reducing the quality of life and expectancy of patients, and imposing a heavy economic burden on society and families. Although initially classified as antidiabetic agents, sodium-glucose co-transporter 2 (SGLT2) inhibitors have demonstrated reduced the prevalence of hospitalization for HF, cardiovascular death, and all-cause death in several large-scale randomized controlled clinical trials. These beneficial effects of SGLT-2 inhibitors can be attributed to multiple hemodynamic, inflammatory and metabolic mechanisms, not only reducing the serum glucose level. SGLT2 inhibitors have been used increasingly in treatment for patients with HF with reduced ejection fraction due to their surprising performance in improving the prognosis. In addition, their roles and mechanisms in patients with HF with preserved ejection fraction or acute HF have also attracted attention. In this review article, we discuss the possible mechanisms and applications of SGLT2 inhibitors in HF.


Hypertension ◽  
2017 ◽  
Vol 70 (suppl_1) ◽  
Author(s):  
Hong Seok Lee ◽  
Nunez Belen ◽  
Hans Cativo ◽  
Amrut Savadkar ◽  
Visco Ferdinand ◽  
...  

Background: Hypertension is the most important modifiable risk factor for worsening heart failure (HF) because hypertension increases cardiac work, which results in worsening left ventricular hypertrophy and development of coronary artery disease. We will determine risk fctors of BP control in different types of heart failure according to JNC 8 guideline. Method: Based on ACC/AHA guidelines, heart failure is classified as a reduced ejection fraction(HFrEF, EF <40), preserved ejection fraction (HFpEF, EF>50) and heart failure with an improved ejection fraction(HFpEF(i),EF≥40). 732 patients enrolled in our heart failure program were analyzed retrospectively. And 672 patients who had been followed from Jan 1 st ,2013 to June 30st 2015 were included. Multiple logistic regression analysis was performed to determine the relationship between hypertension and heart failure after adjusting for potential confounders. Results: Patients with three types of heart failure had different BP control rate. It was 67.5% (308/456) ,76.5%(104/136), 77.5%(62/80) in HFrEF, HFrEF, and HFpEF(i) based on JNC 8 guideline, respectively. Mean systolic BP was 127.1±17 mmHg in HFrEF, 129.0±21 mmHg in HFpEF and 124.4±18 mmHg in HFpEF(i). Obesity [Odds ratio (OR): 0.12,95% Confidence Interval(CI): 0.048-0.284] , ACE inhibitor or ARB [OR: 2.66, CI: 1.50-3.42] and lasix [OR: 1.90,CI: 1.07-3.40] and aspirin [OR 0.53, CI: 0.37-0.96] were noted to be related to controlled BP in HFrEF. Aspirin [OR 0.17, CI: 0.05-0.60] was significantly associated with controlled BP in HFpEF. And beta-blocker [OR: 0.07, CI: 0.01-0.62] and anti-lipid medication [OR: 4.76, CI: 1.73-5.89] were associated with BP control in HFpEF(i). Conclusion: In each type of heart failure, there was difference of risk factors related to BP control. Different medications were associated with control of BP in different types of heart failure. Patients may need to modify risk factors including types of medication to control BP according to types of heart failure. It might be leading to better heart failure management.


2014 ◽  
Vol 16 (9) ◽  
pp. 967-976 ◽  
Author(s):  
Dan Rusinaru ◽  
David Houpe ◽  
Catherine Szymanski ◽  
Franck Lévy ◽  
Sylvestre Maréchaux ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Shahryar M Chowdhury ◽  
carolyn taylor ◽  
Andrew M ATZ

Introduction: The objective of this study was to investigate the association of contractility, afterload, and diastolic dysfunction to exercise function between patients with heart failure and preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF). Hypothesis: Cardiac mechanical determinants of exercise would be different in HFrEF versus HFpEF Methods: Core-lab echocardiograms were obtained from the publically-available Pediatric Heart Network Fontan Cross-sectional Study database. Ejection fraction was considered abnormal if < 50%. Diastolic function was defined as abnormal if the diastolic pressure:volume quotient (lateral E:e’/end-diastolic volume) was > 10 th percentile. Patients were divided into three groups: 1 = normal EF and normal diastolic function, 2 = decreased EF with normal diastolic function (HFrEF), 3 = normal EF with abnormal diastolic function (HFpEF). End-systolic elastance (Ees), a measure of contractility, and arterial elastance (Ea), a measure of afterload, were calculated. Results: 238 patients were included. Differences between groups are reported in the Table. In group 1, there were no significant correlations between exercise and echocardiographic measures. In patients with HFrEF, Ea was correlated with percent predicted max O 2 pulse (ppO 2 P-max) (r = -0.40, p = 0.03). In patients with HFpEF, lateral E:e’/EDV was correlated with ppO 2 P-max (r = -0.57, p = 0.02). No measures correlated with percent predicted peak VO 2 in either group. Conclusions: As Fontan patients progress to heart failure, stroke volume during exercise is limited by afterload in patients with HFrEF. Alternatively, stroke volume is limited by diastolic dysfunction in HFpEF patients. These measures of cardiac mechanics may be useful in identifying the mechanisms that drive exercise dysfunction in Fontan patients of varying heart failure phenotypes.


2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
M. Evangelista ◽  
F. Bandera ◽  
G. Oggionni ◽  
M.C. Palumbo ◽  
M. Barletta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document